| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |